Dual HER2-blockade shows anti-tumour activity in patients with uterine cancer Presented ByDr Eugene Ahn, Cancer Treatment Centers of America, IL, USA TrialPhase 2, TAPUR ConferenceASCO 2021 TypePeer-reviewed article 12 August 2021 21:45